﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Parathyroid Disease</JournalTitle>
      <Issn>2345-6558</Issn>
      <Volume>14</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Decoding immunoporosis-novel insights into immune system dysregulation in bone health and disease</ArticleTitle>
    <FirstPage>e13327</FirstPage>
    <LastPage>e13327</LastPage>
    <ELocationID EIdType="doi">10.34172/jpd.13327</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Aysuliu</FirstName>
        <LastName>Sharopova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0008-8781-8054</Identifier>
      </Author>
      <Author>
        <FirstName>Nodira</FirstName>
        <LastName>Shukurova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-8946-1670</Identifier>
      </Author>
      <Author>
        <FirstName>Maftuna</FirstName>
        <LastName>Aliyeva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-5660-492X</Identifier>
      </Author>
      <Author>
        <FirstName>Gulshod</FirstName>
        <LastName>Usmonova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7247-8386</Identifier>
      </Author>
      <Author>
        <FirstName>Zulfiya</FirstName>
        <LastName>Davlyatova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0005-8594-5998</Identifier>
      </Author>
      <Author>
        <FirstName>Munira</FirstName>
        <LastName>Payziyeva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0000-1400-7287</Identifier>
      </Author>
      <Author>
        <FirstName>Iroda</FirstName>
        <LastName>Tishabayeva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0001-3081-8917</Identifier>
      </Author>
      <Author>
        <FirstName>Fayzulla</FirstName>
        <LastName>Yuldashov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0007-9226-9857</Identifier>
      </Author>
      <Author>
        <FirstName>Tulkin</FirstName>
        <LastName>Elmurodov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0002-4223-4334</Identifier>
      </Author>
      <Author>
        <FirstName>Adkhambek</FirstName>
        <LastName>Nurboboyev</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3835-2445</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jpd.13327</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>05</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>06</Month>
        <Day>27</Day>
      </PubDate>
    </History>
    <Abstract>Immunoporosis represents a novel field that investigates the crucial role of immune system dysregulation in bone health and disease, particularly in conditions like osteoporosis. Traditionally, osteoporosis has been viewed primarily as a bone remodeling disorder influenced by factors such as estrogen deficiency or aging. However, recent advancements in osteoimmunology have highlighted the extensive communication between bone and the immune system in maintaining skeletal homeostasis. The term immunoporosis emphasizes on the significant impact of immune cells and inflammatory factors on the pathophysiology of osteoporosis. This paradigm shift recognizes osteoporosis as a chronic immune-mediated disease. The immune system influences bone remodeling and regulates bone mass through the production of various cytokines, chemokines, and growth factors. Inflammatory bone conditions, including osteoporosis, often arise from a dysregulation in the intricate balance between the bone and immune systems. Both innate and adaptive immune cells and their secretory cytokines are crucial players in skeletal homeostasis. For instance, immune cells can directly influence bone health, and the dysregulation of immune function can lead to abnormal bone conditions. The interplay between these systems offers promising avenues for developing immunomodulatory treatments for osteoporosis and other bone pathologies. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Osteoimmunology</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Osteoporosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Bone</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Vitamin D</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Immunoporosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cytokines</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>